The Effect of Adenomoyosis on Pregnancy Outcomes

checkorphan
Learn more about:
Adenomyosis
Related Clinical Trial
The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis Long-term Use of Mifepristone in the Treatment of Adenomyosis Radiofrequency Ablation of Adenomyosis Determination of the Incidence of Endometriosis and or Adenomyosis in Patients Diagnosed With Polycystic Ovary Syndrome, or the Incidence of Polycystic Ovary Syndrome in Patients Diagnosed With Endometriosis and or Adenomyosis The Effect of Adenomoyosis on Pregnancy Outcomes Observational Study of Patients Suffering From Endometriosis and Adenomyosis Factors Associated With Adenomyosis and a Clinical Scoring System for the Diagnosis Quality of Life After Hysterectomy (AdenoQOL) Low Molecular Weight Heparin on the Adenomyosis Patients’IVF-ET Outcome Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI Clinical and Molecular Study of Endometriosis and Adenomyosis Surgical Success After Laparoscopic vs Abdominal Hysterectomy Electronic Catheter Stethoscope Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? Single-port Access Laparoscopic-assisted Vaginal Hysterectomy Uterine Artery Embolization for Symptomatic Fibroids Oxytocin in MRI-HIFU To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy Effect of Addition of Steroids on Duration of Analgesia Paracervical Block in Laparoscopic Hysterectomy Use of Dexamethasone in Uterine Artery Embolization Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS) Dienogest for Treatment of Adenomyotic Uteri Health-Related QoL Among Women Receiving Hysterectomy in NTUH Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis Adenomyosis and Ulipristal Acetate Efficacy of Acupuncture on Chronic Pelvic Pain in Women With Endometriosis or Adenomyosis LNG-IUS for Treatment of Dysmenorrhea Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis Adenomyosis: Genomic Mechanisms and Biological Response What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography Comparing Efficacy of Microwave vs Embolization Treatment for Adenomyosis Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis A Prospective Study of Diagnostic Accuracy of Ultrasound Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis A Multi-omics Study of Adenomyosis Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis Levonorgestrel Intrauterine System and Adenomyosis Validation of the Adenomyosis Calculator Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer. New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms High-intensity Focused Ultrasound in Treatment of Uterine Adenomyosis Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis Norwegian Adenomyosis Study III: Peristalsis Histopathological Diagnosis of Adenomyosis Norwegian Adenomyosis Study I Vaginal Bromocriptine for Treatment of Adenomyosis Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis

Brief Title

The Effect of Adenomoyosis on Pregnancy Outcomes

Official Title

Adverse Obstetrical Outcomes for Women With Adenomyosis

Brief Summary

      Adenomyosis can be defined as the settling of endometrial gland cells in the myometrium and
      deformity in the uterus and the prevalence of adenomyosis is according to the patient
      population and countries around 20%. There are recent publications reporting that this rate
      increases up to 50% in women dealing with infertility. In adenomyosis, where uterine
      morphology is affected, it is not thought that the uterus, which is expected to provide many
      morphological adaptations during pregnancy, will not be affected. Therefore, in this
      prospective study, it was planned to investigate the effects of adenomyosis during pregnancy.

      For this study the presence of adenomyosis will be questioned by using ultrasonographic
      morphological uterine limitation (MUSA) in women who apply to the outpatient clinic with
      suspicion of pregnancy and undergo transvaginal ultrasonography for the diagnosis of
      pregnancy before sixth gestational week.

      Patients will be divided into two groups according to the presence of adenomyosis and
      pregnancy complications such as preterm labor, premature rupture of membranes, cesarean
      section rates, preeclampsia, fetal malpresentation and preeclampsia will be compared between
      the groups.

Study Type

Observational [Patient Registry]

Primary Outcome

Pregnancy complication

Secondary Outcome

 Pregnancy complication

Condition

Adenomyosis

Intervention

Non intervention

Study Arms / Comparison Groups

 Adenomyosis Group
Description:

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status

Other

Estimated Enrollment

150

Start Date

May 20, 2021

Completion Date

December 2022

Primary Completion Date

August 2022

Eligibility Criteria

        Inclusion Criteria:

          -  Age between 18-35 years

          -  Being diagnosed before the 6th gestational week

          -  Having all pregnancy follow-ups and deliveries in our hospital

        Exclusion Criteria:

          -  Previous uterine surgery

          -  Multiple pregnancies

          -  Pregnant women with uterine malformations

          -  Pregnant women with fetal anomalies

          -  Those who got pregnant using assisted reproductive technique

Gender

Female

Ages

18 Years - 35 Years

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

Ahkam Göksel Kanmaz, Assoc. Prof., (0232) 373 89 21, [email protected]

Location Countries

Turkey

Location Countries

Turkey

Administrative Informations

NCT ID

NCT04894292

Organization ID

TepecikTRH-001

Responsible Party

Principal Investigator

Study Sponsor

Tepecik Training and Research Hospital

Study Sponsor

Ahkam Göksel Kanmaz, Assoc. Prof., Study Director, Tepecik Education and Research Hospital

Verification Date

May 2021